{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:38Z","timestamp":1793413478380,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-113361RB-I00"],"award-info":[{"award-number":["PID2020-113361RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78967-2","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T07:21:05Z","timestamp":1731309665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Resveratrol protects pancreatic beta cell and hippocampal cells from the aggregate-prone capacity of hIAPP"],"prefix":"10.1038","volume":"14","author":[{"given":"Carlos","family":"Gonz\u00e1lez-Blanco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela Cristina","family":"Lockwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Iglesias-Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Marqu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garc\u00eda-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"78967_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1871530318666180821161825","volume":"19","author":"Y Saisho","year":"2019","unstructured":"Saisho, Y. Changing the concept of type 2 diabetes: beta cell workload hypothesis revisited. Endocr. Metab. Immune Disord. Drug Targets. 19, 121\u2013127 (2019).","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"78967_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fendo.2018.00621","volume":"9","author":"C Guill\u00e9n","year":"2018","unstructured":"Guill\u00e9n, C. & Benito, M. mTORC1 overactivation as a key aging factor in the progression to type 2 diabetes Mellitus. Front. Endocrinol. (Lausanne) 9, 621 (2018).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"78967_CR3","doi-asserted-by":"publisher","first-page":"976465","DOI":"10.3389\/fendo.2022.976465","volume":"13","author":"S You","year":"2022","unstructured":"You, S., Zheng, J., Chen, Y. & Huang, H. Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus. Front. Endocrinol. (Lausanne) 13, 976465 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"78967_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/antiox10040526","volume":"10","author":"S Ben\u00e1kova","year":"2021","unstructured":"Ben\u00e1kova, S., Holendov\u00e1, B. & Plecit\u00e1-Hlavat\u00e1, L. Redox homeostasis in pancreatic \u03b2-Cells: from development to failure. Antioxidants (Basel) 10, 526 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"78967_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2012.07.029","volume":"150","author":"C Talchai","year":"2012","unstructured":"Talchai, C., Xuan, S., Lin, H. V., Sussel, L. & Accili, D. Pancreatic \u03b2 cell dedifferentiation as a mechanism of diabetic \u03b2 cell failure. Cell. 150, 1223\u20131234. https:\/\/doi.org\/10.1016\/j.cell.2012.07.029 (2012).","journal-title":"Cell"},{"key":"78967_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/cells7080095","volume":"7","author":"Y Kiriyama","year":"2018","unstructured":"Kiriyama, Y. & Nochi, H. Role and cytotoxicity of amylin and protection of pancreatic islet \u03b2-cells from amylin cytotoxicity. Cells 7, 95 (2018).","journal-title":"Cells"},{"key":"78967_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1152\/physrev.00042.2009","volume":"91","author":"P Westermark","year":"2011","unstructured":"Westermark, P., Andersson, A. & Westermark, G. T. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol. Rev. 91, 795\u2013826 (2011).","journal-title":"Physiol. Rev."},{"key":"78967_CR8","doi-asserted-by":"crossref","unstructured":"Akter, R. et al. Islet amyloid polypeptide: structure, function, and pathophysiology. J. Diabetes Res. 2016, 2798269. (2016).","DOI":"10.1155\/2016\/2798269"},{"key":"78967_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-018-0533-x","volume":"9","author":"M Garc\u00eda-Hern\u00e1ndez","year":"2018","unstructured":"Garc\u00eda-Hern\u00e1ndez, M. et al. Pancreatic \u03b2 cells overexpressing hIAPP impaired mitophagy and unbalanced mitochondrial dynamics. Cell. Death Dis. 9, 481 (2018).","journal-title":"Cell. Death Dis."},{"key":"78967_CR10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed, A., Kim, E. & Jacinto, E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol. Rev. 101, 1371\u20131426 (2021).","journal-title":"Physiol. Rev."},{"key":"78967_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tcb.2012.02.006","volume":"22","author":"C Appenzeller-Herzog","year":"2012","unstructured":"Appenzeller-Herzog, C. & Hall, M. N. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol. 22, 274\u2013282 (2012).","journal-title":"Trends Cell Biol."},{"key":"78967_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz, C., Zhang, K. & Kaufman, R. J. Mechanisms, regulation and functions of the unfolded protein response. Nat. Rev. Mol. Cell. Biol. 21, 421\u2013438 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"78967_CR13","doi-asserted-by":"publisher","first-page":"e01577","DOI":"10.1002\/brb3.1577","volume":"10","author":"J Madhusudhanan","year":"2020","unstructured":"Madhusudhanan, J., Suresh, G. & Devanathan, V. Neurodegeneration in type 2 diabetes: Alzheimer\u2019s as a case study. Brain Behav. 10, e01577 (2020).","journal-title":"Brain Behav."},{"key":"78967_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/cells10051236","volume":"10","author":"J Burillo","year":"2021","unstructured":"Burillo, J. et al. Insulin resistance and diabetes mellitus in Alzheimer\u2019s disease. Cells 10, 1236 (2021).","journal-title":"Cells"},{"key":"78967_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.25570","volume":"86","author":"I Mart\u00ednez-Valbuena","year":"2019","unstructured":"Mart\u00ednez-Valbuena, I. et al. Amylin as a potential link between type 2 diabetes and Alzheimer disease. Ann. Neurol. 86, 539\u2013551 (2019).","journal-title":"Ann. Neurol."},{"key":"78967_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-161192","volume":"59","author":"P Bharadwaj","year":"2017","unstructured":"Bharadwaj, P. et al. The link between type 2 diabetes and neurodegeneration: roles for Amyloid-\u03b2, Amylin, and Tau Proteins. J. Alzheimers Dis. 59, 421\u2013432 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"78967_CR17","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara, N. et al. Amyloid-\u03b2 and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J. 31, 5409\u20135418 (2017).","journal-title":"FASEB J."},{"key":"78967_CR18","doi-asserted-by":"publisher","first-page":"576192","DOI":"10.3389\/fnagi.2020.576192","volume":"12","author":"G Ho","year":"2020","unstructured":"Ho, G. et al. Connecting Alzheimer\u2019s disease with diabetes mellitus through amyloidogenic evolvability. Front. Aging Neurosci. 12, 576192 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"78967_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bcp.2013.12.023","volume":"88","author":"MJ Guerrero-Mu\u00f1oz","year":"2014","unstructured":"Guerrero-Mu\u00f1oz, M. J., Castillo-Carranza, D. L. & Kayed, R. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins. Biochem. Pharmacol. 88, 468\u2013478 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"78967_CR20","doi-asserted-by":"crossref","unstructured":"Fantacuzzi, M., Amoroso, R., Carradori, S. & De Filippis, B. Resveratrol-based compounds and neurodegeneration: recent insight in multitarget therapy. Eur. J. Med. Chem., 233114242. (2022).","DOI":"10.1016\/j.ejmech.2022.114242"},{"key":"78967_CR21","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud, P., Zhao, H. & Davies, P. Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J. Biol. Chem. 280, 37377\u201337382 (2005).","journal-title":"J. Biol. Chem."},{"key":"78967_CR22","doi-asserted-by":"publisher","first-page":"843","DOI":"10.4103\/1673-5374.268970","volume":"15","author":"A Freyssin","year":"2020","unstructured":"Freyssin, A., Page, G., Fauconneau, B. & Bilan, A. R. Natural stilbenes effects in animal models of Alzheimer\u2019s disease. Neural Regen. Res. 15, 843\u2013849 (2020).","journal-title":"Neural Regen. Res."},{"key":"78967_CR23","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1007\/s12035-021-02365-2","volume":"58","author":"S Paul","year":"2021","unstructured":"Paul, S., Saha, D. & Bk, B. Mitochondrial dysfunction and mitophagy closely cooperate in neurological deficits associated with alzheimer\u2019s disease and type 2 diabetes. Mol. Neurobiol. 58, 3677\u20133691 (2021).","journal-title":"Mol. Neurobiol."},{"key":"78967_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.cmet.2013.03.002","volume":"17","author":"M Liesa","year":"2013","unstructured":"Liesa, M. & Shirihai, O. S. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell. Metab. 17, 491\u2013506 (2013).","journal-title":"Cell. Metab."},{"key":"78967_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","volume":"15","author":"DC Chan","year":"2020","unstructured":"Chan, D. C. Mitochondrial dynamics and its involvement in disease. Annu. Rev. Pathol. 15, 235\u2013259 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"78967_CR26","doi-asserted-by":"publisher","first-page":"118971","DOI":"10.1016\/j.bbamcr.2021.118971","volume":"1868","author":"J Burillo","year":"2021","unstructured":"Burillo, J. et al. Human amylin aggregates release within exosomes as a protective mechanism in pancreatic \u03b2 cells: pancreatic \u03b2-hippocampal cell communication. Biochim. Biophys. Acta Mol. Cell. Res. 1868, 118971 (2021).","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"78967_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/antiox10020142","volume":"10","author":"A Garc\u00eda-Aguilar","year":"2021","unstructured":"Garc\u00eda-Aguilar, A., Palomino, O., Benito, M. & Guill\u00e9n, C. Dietary polyphenols in metabolic and neurodegenerative diseases: molecular targets in autophagy and biological effects. Antioxidants (Basel) 10, 142 (2021).","journal-title":"Antioxidants (Basel)"},{"key":"78967_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1021\/ml3003605","volume":"4","author":"M Staderini","year":"2012","unstructured":"Staderini, M. et al. A fluorescent styrilquinoline with combined therapeutic and diagnostic activities against Alzheimer\u2019s and prion diseases. ACS Med. Chem. Lett. 4, 225\u2013229 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"78967_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"E Macia","year":"2006","unstructured":"Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839\u2013850. https:\/\/doi.org\/10.1016\/j.devcel.2006.04.002 (2006).","journal-title":"Dev. Cell"},{"key":"78967_CR30","doi-asserted-by":"publisher","first-page":"40857","DOI":"10.1074\/jbc.M111.232801","volume":"286","author":"M Soty","year":"2022","unstructured":"Soty, M. et al. A involvement of ATP-sensitive potassium (K(ATP)) channels in the loss of beta-cell function induced by human islet amyloid polypeptide. J. Biol. Chem. 286, 40857\u201340866 (2022).","journal-title":"J. Biol. Chem."},{"key":"78967_CR31","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.chemphyslip.2020.105010","volume":"234","author":"A El Saghir","year":"2021","unstructured":"El Saghir, A., Farrugia, G. & Vasallo, N. The human islet amyloid polypeptide in protein misfolding disorders: mechanisms of aggregation and interaction with biomembranes. Chem. Phys. Lipids 234, 105010 (2021).","journal-title":"Chem. Phys. Lipids"},{"key":"78967_CR32","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1021\/bi501016r","volume":"54","author":"L-H Tu","year":"2015","unstructured":"Tu, L-H. et al. Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions. Biochemistry 54, 666\u2013676 (2015).","journal-title":"Biochemistry"},{"key":"78967_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ejmech.2015.01.047","volume":"92","author":"F Lolicato","year":"2015","unstructured":"Lolicato, F., Raudino, A., Milardi, D. & La Rosa, C. Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. Eur. J. Med. Chem. 92, 876\u2013881 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"78967_CR34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.bpj.2011.02.010","volume":"100","author":"P Jiang","year":"2011","unstructured":"Jiang, P., Li, W., Shea, J-E. & Mu, Y. Resveratrol inhibits the formation of multiple-layered \u03b2-sheet oligomers of the human islet amyloid polypeptide segment 22\u201327. Biophys. J. 100, 1550\u20131558 (2011).","journal-title":"Biophys. J."},{"key":"78967_CR35","doi-asserted-by":"crossref","unstructured":"Pithadia, A., Brender, J. R., Fierke, C. A. & Ramamoorthy, A. Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J. Diabetes Res. 2016, 2046327 (2016).","DOI":"10.1155\/2016\/2046327"},{"key":"78967_CR36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bbamem.2018.03.012","volume":"1860","author":"MFM Sciacca","year":"2018","unstructured":"Sciacca, M. F. M. et al. A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim. Biophys. Acta Biomembr. 1860, 1793\u20131802 (2018).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"78967_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1073\/pnas.0901422106","volume":"106","author":"E Chatani","year":"2009","unstructured":"Chatani, E. et al. Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils. Proc. Natl. Acad. Sci. USA. 106, 1119\u20131124 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"78967_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/endrev\/bnaa005","volume":"41","author":"A D\u00edaz-Vegas","year":"2020","unstructured":"D\u00edaz-Vegas, A. et al. Is mitocondrial dysfunction a common root of noncommunicable chronic diseases? Endocr. Rev. 41, 1\u201327 (2020).","journal-title":"Endocr. Rev."},{"key":"78967_CR39","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2337\/db21-0281","volume":"71","author":"T Israeli","year":"2022","unstructured":"Israeli, T. et al. Nutrient Sensor mTORC1 regulates insulin secretion by modulating \u03b2-cell autophagy. Diabetes 71, 453\u2013469 (2022).","journal-title":"Diabetes"},{"key":"78967_CR40","doi-asserted-by":"publisher","first-page":"1801313","DOI":"10.1002\/advs.201801313","volume":"6","author":"W Zou","year":"2018","unstructured":"Zou, W. et al. Exosome release is regulated by mTORC1. Adv. Sci. (Weinh) 6, 1801313 (2018).","journal-title":"Adv. Sci. (Weinh)"},{"key":"78967_CR41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/biomedicines9080918","volume":"9","author":"H-C Kung","year":"2021","unstructured":"Kung, H-C., Lin, K-J., Kung, C-T. & Lin, T.-K. Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson\u2019s disease. Biomedicines 9, 918 (2021).","journal-title":"Biomedicines"},{"key":"78967_CR42","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.18632\/aging.101966","volume":"11","author":"N Wang","year":"2019","unstructured":"Wang, N. et al. Exploration of age-related mitochondria dysfunction and the anti-aging effects of resveratrol in zebrafish retina. Aging (Albany NY). 11, 3117\u20133137 (2019).","journal-title":"Aging (Albany NY)"},{"key":"78967_CR43","doi-asserted-by":"publisher","first-page":"e1700941","DOI":"10.1002\/mnfr.201700941","volume":"62","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Resveratrol improves muscle atrophy by modulating mitochondrial quality control in STZ-induced diabetic mice. Mol. Nutr. Food Res. 62, e1700941 (2018).","journal-title":"Mol. Nutr. Food Res."},{"key":"78967_CR44","doi-asserted-by":"crossref","unstructured":"Ren, X. et al. Resveratrol ameliorates mitochondrial elongation via Drp1\/Parkin\/PINK1 signaling in senescent-like cardiomyocytes. Oxid. Med. Cell Longev. 2017, 4175353 (2017).","DOI":"10.1155\/2017\/4175353"},{"key":"78967_CR45","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong, J. L. Y., De Pablo-Fern\u00e1ndez, E., Foltynie, T. & Noyce, A. J. The association between type 2 diabetes mellitus and Parkinson\u2019s disease. J. Parkinsons Dis. 10, 775\u2013789 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"78967_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-210612","volume":"85","author":"J Lynn","year":"2022","unstructured":"Lynn, J., Park, M., Ogunwale, C. & Acquaah-Mensah, G. A tale of two diseases: exploring mechanisms linking diabetes mellitus with Alzheimer\u2019s disease. J. Alzheimers Dis. 85, 485\u2013501 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"78967_CR47","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1007\/s12035-018-1025-9","volume":"55","author":"A Biosa","year":"2018","unstructured":"Biosa, A., Outeiro, T. F., Bubacco, L. & Bisaglia, M. Diabetes mellitus as a risk factor for Parkinson\u2019s disease: a molecular point of view. Mol. Neurobiol. 55, 8754\u20138763 (2018).","journal-title":"Mol. Neurobiol."},{"key":"78967_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2020.00035","volume":"13","author":"AF Raimundo","year":"2020","unstructured":"Raimundo, A. F., Ferreira, S., Martins, I. C. & Menezes, R. Islet amyloid polypeptide: a partner in crime with A\u03b2 in the pathology of Alzheimer\u2019s disease. Front. Mol. Neurosci. 13, 35 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"78967_CR49","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.3390\/ijms23084348","volume":"23","author":"Y-M Yoo","year":"2022","unstructured":"Yoo, Y-M., Jung, E-M., Jeung, E-B., Jo, B. R. & Joo, S. S. Amylin protein expression in the rat brain and Neuro-2a cells. Int. J. Mol. Sci. 23, 4348 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"78967_CR50","doi-asserted-by":"publisher","first-page":"36086","DOI":"10.1074\/jbc.M111.240762","volume":"286","author":"S Trikha","year":"2011","unstructured":"Trikha, S. & Jeremic, A. M. Clustering and internalization of toxic amylin oligomers in pancreatic cells require plasma membrane cholesterol. J. Biol. Chem. 286, 36086\u201336097 (2011).","journal-title":"J. Biol. Chem."},{"key":"78967_CR51","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/mds.28639","volume":"36","author":"A Stuendl","year":"2021","unstructured":"Stuendl, A. et al. \u03b1-synuclein in plasma-derived extracellular vesicles is a potential biomarker of Parkinson\u2019s disease. Mov. Disord. 36, 2508\u20132518 (2021).","journal-title":"Mov. Disord."},{"key":"78967_CR52","doi-asserted-by":"publisher","first-page":"114183","DOI":"10.1016\/j.expneurol.2022.114183","volume":"358","author":"P Gomes","year":"2022","unstructured":"Gomes, P. et al. Extracellular vesicles and Alzheimer\u2019s disease I the novel era of precision medicine: implications for disease progression, diagnosis and treatment. Exp. Neurol. 358, 114183 (2022).","journal-title":"Exp. Neurol."},{"key":"78967_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2021.08.049","volume":"574","author":"E Chau","year":"2021","unstructured":"Chau, E., Kim, H., Shin, J., Mart\u00ednez, A. & Kim, J. R. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative. Biochem. Biophys. Res. Commun. 574, 85\u201390 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"78967_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neurobiolaging.2020.04.012","volume":"94","author":"S Al-Edresi","year":"2020","unstructured":"Al-Edresi, S., Alsalahat, I., Freeman, S., Aojula, H. & Penny, J. Resveratrol-mediated cleavage of amyloid \u03b21\u201342 peptide: potential relevance to Alzheimer\u2019s disease. Neurobiol. Aging 94, 24\u201333 (2020).","journal-title":"Neurobiol. Aging"},{"key":"78967_CR55","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00394-015-0894-1","volume":"55","author":"C Regitz","year":"2016","unstructured":"Regitz, C., Fitzenberger, E., Mahn, F. L., Du\u00dfling, L. M. & Wenzel, U. Resveratrol reduces amyloid-beta (A\u03b2\u2081\u208b\u2084\u2082)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. Eur. J. Nutr. 55, 741\u2013747 (2016).","journal-title":"Eur. J. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78967-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:13:50Z","timestamp":1731672830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78967"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78967-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27523"}}